This study seeks to determine if variation in the dopamine transporter gene ( SLC6A3/DAT1 ) moderates the dose-response effects of long-acting dexmethylphenidate ( D-MPH ) and mixed amphetamine salts ( MAS ) in children with attention-deficit/hyperactivity disorder ( ADHD ) .